Emerging CAR T cell therapies: clinical landscape and patent technological routes (2020)
- Authors:
- USP affiliated authors: CASTRO, VIRGÍNIA PICANÇO E - FMRP ; ANTONIETTO, KAMILLA SWIECH - FCFRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; COVAS, DIMAS TADEU - FMRP ; PORTO, GECIÂNE SILVEIRA - FEARP
- Unidades: FMRP; FCFRP; FEARP
- DOI: 10.1080/21645515.2019.1689744
- Subjects: PATENTE; TECNOLOGIA; CÉLULAS; TESTES LABORATORIAIS; INOVAÇÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Human Vaccines & Immunotherapeutics
- ISSN: 2164-554X
- Volume/Número/Paginação/Ano: v. 16, n. 6, p. 1424–1433, 2020
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
PICANÇO-CASTRO, Virgínia et al. Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, v. 16, n. 6, p. 1424–1433, 2020Tradução . . Disponível em: https://doi.org/10.1080/21645515.2019.1689744. Acesso em: 30 mar. 2026. -
APA
Picanço-Castro, V., Pereira, C. G., Swiech, K., Farias, K. C. R. M. de, Covas, D. T., & Porto, G. S. (2020). Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, 16( 6), 1424–1433. doi:10.1080/21645515.2019.1689744 -
NLM
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2026 mar. 30 ] Available from: https://doi.org/10.1080/21645515.2019.1689744 -
Vancouver
Picanço-Castro V, Pereira CG, Swiech K, Farias KCRM de, Covas DT, Porto GS. Emerging CAR T cell therapies: clinical landscape and patent technological routes [Internet]. Human Vaccines & Immunotherapeutics. 2020 ; 16( 6): 1424–1433.[citado 2026 mar. 30 ] Available from: https://doi.org/10.1080/21645515.2019.1689744 - Chimeric antigen receptor T Cell: development and production
- Chimeric antigen receptor T Cells: development and production
- Immunotherapy is a treatment that boosts the body’s natural defenses to fight cancer. [Prefácio]
- Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment
- CAR-T cells for cancer treatment: current design and next frontiers
- Emerging patent landscape for non-viral vectors used for gene therapy
- Production of recombinant coagulation factors:: are humans the best host cells?
- Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells
- A Fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human Mesenchymal stem/stromal cells
- Production of coagulation factor VII in human cell lines Sk-Hep-1 and HKB-11
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003067451.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
